Castle Biosciences, Inc. Banner Image

Castle Biosciences, Inc. has reached its limit for free report views

Work for Castle Biosciences, Inc.? Upgrade Your Profile and unlock all your annual reports.

Castle Biosciences, Inc.

  • Ticker CSTL
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Castle Biosciences, Inc. Logo Image
  • 51-200 Employees
  • Based in Friendswood, Texas
Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com), cutaneous squamousMore cell carcinoma (DecisionDx®-SCC, www.mySCCskincancer.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com). Castle also has products in development for other underserved cancers, the most advanced of which is focused on patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.
Castle Biosciences, Inc.

Most Recent Annual Report

Castle Biosciences, Inc. MOST RECENT 2020 Annual Report

Report Locked. Castle Biosciences, Inc. has reached its limit for free report views.

Older/Archived Annual Reports